IBM is banking on artificial intelligence (AI) and connected devices to find new ways to help people stay healthy, as the world copes with an ageing population and prevalent chronic diseases. Some of the chronic diseases being investigated by IBM include diabetes, Alzheimer’s, dementia and Parkinson’s. IBM has sharpened its focus on studying the world’s ageing population, especially those burdened with chronic diseases, Morimoto said. While most of the technologies IBM is using for its research on chronic diseases are still in the development stage, the US company is borrowing from some real-world applications in the medical field. IBM, which is pursuing initiatives in the medical field with its Watson suite of AI services, applications and tools, is not the only major hi-tech firm working on using AI technologies in health care.

Source: The Star May 28, 2019 06:46 UTC